Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

CRC × spartalizumab × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 28 Carcinoma, Non-Small-Cell Lung 28 Neoplasm Metastasis 23 Carcinoma, Hepatocellular 22 Colorectal Neoplasms 19 Triple Negative Breast Neoplasms 16 Pancreatic Neoplasms 15 Neoplasms 15 Stomach Neoplasms 14 Squamous Cell Carcinoma of Head and Neck 13 Nasopharyngeal Carcinoma 13 Carcinoma, Renal Cell 12 Uterine Cervical Neoplasms 10 Rectal Neoplasms 9 Lymphoma 8 Esophageal Squamous Cell Carcinoma 7 Esophageal Neoplasms 7 Sarcoma 6 Recurrence 6 Lymphoma, Extranodal NK-T-Cell 6 Lung Neoplasms 6 Breast Neoplasms 6 Advanced Solid Tumor 6 Ovarian Neoplasms 5 Locally Advanced Rectal Cancer 5 Liver Neoplasms 5 Glioblastoma 5 Endometrial Neoplasms 5 Cholangiocarcinoma 5 Small Cell Lung Carcinoma 4

Interventions

Leucovorin 2 Irinotecan 2 Fluorouracil 2 Cetuximab 2 spartalizumab 1 pembrolizumab 1 camrelizumab 1 Radiosurgery 1 Oxaliplatin 1 Oncolytic Virotherapy 1 KD025 1 IFL protocol 1 HLX07 1 Folfox protocol 1 Drug Therapy 1 CCT239065 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07381309 2026-02-02

VVSHIP

Sixth Affiliated Hospital, Sun Yat-sen University

Phase 2 Not yet recruiting

Gastrointestinal

CRC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡